130 related articles for article (PubMed ID: 36055919)
21. Diagnostic Dilemma: Primary Peritoneal Mesothelioma With Para-Occupational Asbestos Exposure.
Qin KR; Dua D
J Glob Oncol; 2017 Dec; 3(6):828-832. PubMed ID: 29244982
[No Abstract] [Full Text] [Related]
22. Clinical Response of Primary Malignant Pericardial Mesothelioma with Peritoneal Dissemination to Nivolumab.
Fujiwara S; Kano Y; Maejima Y; Fujioka T; Tamura K; Kirimura S; Miyake S; Okamoto R
Intern Med; 2024 Feb; 63(4):513-519. PubMed ID: 37380459
[TBL] [Abstract][Full Text] [Related]
23. Salvage Resection After Immunotherapy in Refractory Malignant Pleural Mesothelioma.
Banks KC; Chaudhary MJ; Hsu DS; Mooney CM; Velotta JB
Ann Thorac Surg; 2022 Nov; 114(5):e357-e359. PubMed ID: 35104447
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features of patients with malignant peritoneal mesothelioma initially presenting as a local inflammation].
Song H; Zheng G; Wei S; Yang Y; Wei X
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):312-3. PubMed ID: 24989921
[No Abstract] [Full Text] [Related]
25. Effectiveness of Nivolumab on Sarcomatoid Malignant Pleural Mesothelioma With Eosinophilia and Eosinophilic Pleural Effusion.
Yamazoe M; Ozasa H; Kim YH
J Thorac Oncol; 2019 Nov; 14(11):e251-e253. PubMed ID: 31668324
[No Abstract] [Full Text] [Related]
26. Cisplatin plus pemetrexed therapy and subsequent immune checkpoint inhibitor administration for malignant peritoneal mesothelioma without pleural lesions: Case report.
Ikushima H; Sakatani T; Ohara S; Takeshima H; Horiuchi H; Morikawa T; Usui K
Medicine (Baltimore); 2020 May; 99(22):e19956. PubMed ID: 32481365
[TBL] [Abstract][Full Text] [Related]
27. FDA Approves Nivolumab Plus Ipilimumab for Previously Untreated Unresectable Malignant Pleural Mesothelioma.
Wright K
Oncology (Williston Park); 2020 Nov; 34(11):502-503. PubMed ID: 33206991
[TBL] [Abstract][Full Text] [Related]
28. [A case of malignant peritoneal mesothelioma with a good response to treatment].
Mihara N; Hachisuga T; Yamasaki S; Fukuda K; Iwasaka G; Sugimori H; Miyahara S
Gan No Rinsho; 1987 Dec; 33(15):1939-44. PubMed ID: 3430746
[TBL] [Abstract][Full Text] [Related]
29. Laparoscopy and primary diffuse malignant peritoneal mesothelioma: a diagnostic challenge.
Van de Walle P; Blomme Y; Van Outryve L
Acta Chir Belg; 2004 Feb; 104(1):114-7. PubMed ID: 15053478
[TBL] [Abstract][Full Text] [Related]
30. Diffuse malignant peritoneal mesothelioma in a 13-year-old girl. Report of a case and review of the literature.
Talerman A; Montero JR; Chilcote RR; Okagaki T
Am J Surg Pathol; 1985 Jan; 9(1):73-80. PubMed ID: 3970301
[TBL] [Abstract][Full Text] [Related]
31. Benefit with first-line ICIs in mesothelioma.
Romero D
Nat Rev Clin Oncol; 2021 Apr; 18(4):194. PubMed ID: 33536633
[No Abstract] [Full Text] [Related]
32. Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study.
Kitadai R; Shimoi T; Sudo K; Noguchi E; Nagata Y; Sawada R; Takashima A; Boku N; Yonemori K
BMC Cancer; 2021 Mar; 21(1):294. PubMed ID: 33743636
[TBL] [Abstract][Full Text] [Related]
33. CheckMate 743: A Glimmer of Hope for Malignant Pleural Mesothelioma.
Uprety D
Clin Lung Cancer; 2021 Mar; 22(2):71-73. PubMed ID: 33358660
[No Abstract] [Full Text] [Related]
34. Diffuse malignant biphasic peritoneal mesothelioma with cystic areas.
Cabibi D; Tutino R; Salamone G; Cocorullo G; Agrusa A; Gulotta G
Ann Ital Chir; 2016 Jun; 87():. PubMed ID: 27320084
[TBL] [Abstract][Full Text] [Related]
35. The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma.
Banerji S; Meyers DE; Harlos C; Dawe DE
Curr Oncol; 2021 Nov; 28(6):4542-4551. PubMed ID: 34898559
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy maintenance: an option for prolonged survival in malignant peritoneal mesothelioma?
Hofer S; Sasse B; Scheffel H
Acta Oncol; 2010; 49(1):122-4. PubMed ID: 20104656
[No Abstract] [Full Text] [Related]
37. Malignant peritoneal mesothelioma in children: description of two cases and review of the literature.
Kovalivker M; Motovic A
J Pediatr Surg; 1985 Jun; 20(3):274-5. PubMed ID: 4009380
[TBL] [Abstract][Full Text] [Related]
38. Desmoplastic malignant mesothelioma originating from the peritoneum.
Takamaru H; Arimura Y; Shinomura Y
Med Oncol; 2012 Dec; 29(5):3155-6. PubMed ID: 22744710
[No Abstract] [Full Text] [Related]
39. Occurrence of malignant peritoneal mesothelioma after surgery and irradiation for cervical cancer.
Beier KM; Gallup DG; Burgess R; Stock RJ
Gynecol Oncol; 1984 Mar; 17(3):375-80. PubMed ID: 6706236
[TBL] [Abstract][Full Text] [Related]
40. Malignant peritoneal mesothelioma in a pediatric patient mimicking inflammatory bowel disease.
Oberto C; Schwarz KB; Zambidis E; Campbell AB; Paidas C; Lindyberg K; Oliva-Hemker M
Dig Dis Sci; 2004 Mar; 49(3):434-7. PubMed ID: 15139493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
